Immune-related tumor response dynamics in melanoma patients treated with pembrolizumab: identifying markers for clinical outcome and treatment decisions

M Nishino, A Giobbie-Hurder, MP Manos, N Bailey… - Clinical Cancer …, 2017 - AACR
Purpose: Characterize tumor burden dynamics during PD-1 inhibitor therapy and investigate
the association with overall survival (OS) in advanced melanoma. Experimental Design: The …
被引用次数：140 相关文章
[PDF] amazonaws.com

[PDF][PDF] Immune-Related Tumor Response Dynamics in Melanoma Patients Treated with Pembrolizumab: Identifying Markers for Clinical Outcome and Treatment …

M Nishino, A Giobbie-Hurder, MP Manos, N Bailey… - tekinvestor.s3.dualstack.eu-west-1 …
Purpose: Characterize tumor burden dynamics during PD-1 inhibitor therapy and investigate
the association with overall survival (OS) in advanced melanoma. Experimental Design: The …
[HTML] nih.gov

[HTML][HTML] Immune-related tumor response dynamics in melanoma patients treated with pembrolizumab: Identifying markers for clinical outcome and treatment decisions

M Nishino, A Giobbie-Hurder, MP Manos… - … cancer research: an …, 2017 - ncbi.nlm.nih.gov
Immune-related tumor response dynamics in melanoma patients treated with
pembrolizumab: Identifying markers for clinical outcome and treatment decisions - PMC …
[PDF] tekinvestor.no

[PDF][PDF] Immune-Related Tumor Response Dynamics in Melanoma Patients Treated with Pembrolizumab: Identifying Markers for Clinical Outcome and Treatment …

M Nishino, A Giobbie-Hurder, MP Manos, N Bailey… - tekinvestor.no
Purpose: Characterize tumor burden dynamics during PD-1 inhibitor therapy and investigate
the association with overall survival (OS) in advanced melanoma. Experimental Design: The …

Immune-Related Tumor Response Dynamics in Melanoma Patients Treated with Pembrolizumab: Identifying Markers for Clinical Outcome and Treatment Decisions

M Nishino, A Giobbie-Hurder… - … : an official journal …, 2017 - pubmed.ncbi.nlm.nih.gov
Purpose: Characterize tumor burden dynamics during PD-1 inhibitor therapy and investigate
the association with overall survival (OS) in advanced melanoma. Experimental Design: The …

Immune-Related Tumor Response Dynamics in Melanoma Patients Treated with Pembrolizumab: Identifying Markers for Clinical Outcome and Treatment Decisions

M Nishino, A Giobbie-Hurder, MP Manos… - Clinical Cancer …, 2017 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Purpose: Characterize tumor burden dynamics
during PD-1 inhibitor therapy and investigate the association with overall survival (OS) in …

Immune-Related Tumor Response Dynamics in Melanoma Patients Treated with Pembrolizumab: Identifying Markers for Clinical Outcome and Treatment Decisions.

M Nishino, A Giobbie-Hurder, MP Manos… - … Cancer Research: an …, 2017 - europepmc.org
Purpose: Characterize tumor burden dynamics during PD-1 inhibitor therapy and investigate
the association with overall survival (OS) in advanced melanoma. Experimental Design: The …